Osteoclast formation and function in pigmented villonodular synovitis

Journal of Pathology

Volumn 225, Issue 1, 2011, Pages 151-156

  Taylor, Richard ^a   Kashima, Takesh G ^a   Knowles, Helen ^a   Gibbons, C L Max H ^a   Whitwell, Duncan ^a   Athanasou, Nicholas A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

bisphosphonate; bone resorption; osteoclasts; pigmented villonodular synovitis (PVNS); synovium

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CD14 ANTIGEN; CD51 ANTIGEN; COLONY STIMULATING FACTOR 1; HLA DR ANTIGEN; OSTEOCLAST DIFFERENTIATION FACTOR; ZOLEDRONIC ACID;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CELL CULTURE; CELL ISOLATION; CELL POPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GIANT CELL; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; MALE; MONONUCLEAR CELL; MULTINUCLEAR CELL; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHAGOCYTE; PHENOTYPE; PIGMENTED VILLONODULAR SYNOVITIS; PRIORITY JOURNAL; SYNOVIUM;

ADOLESCENT; ADULT; ANTIGENS, CD14; BONE RESORPTION; CELLS, CULTURED; FEMALE; GIANT CELLS; HUMANS; IMMUNOPHENOTYPING; KNEE JOINT; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; SYNOVIAL MEMBRANE; SYNOVITIS, PIGMENTED VILLONODULAR; YOUNG ADULT;

EID: 79960726948     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2937     Document Type: Article

References (29)

1. Rao AS, Vigorita VJ,. Pigmented villonodular synovitis (giant-cell tumour of the tendon sheath and synovial membrane). A review of eighty-one cases. J Bone Joint Surg 1984; 66A: 76-94. (Pubitemid 14186734)
2. de St Aubain Somerhausen N, Dallin P,. Diffuse type giant cell tumour. In Tumours of Soft Tissue and Bone with Classification of Tumours, Fletcher CDM, Unni KK, Mertens F, (eds). IARC Press: Lyons, 2002; 112-114.
3. Byers PD, Cotton RE, Deacon OW, et al., The diagnosis and treatment of pigmented villonodular synovitis. J Bone Joint Surg 1968; 50B: 290-305.
4. Flandry F, Hughston J,. Pigmented villonodular synovitis. J Bone Joint Surg 1987; 69A: 942-949.
5. Fletcher JA, Henkle C, Atkins L, et al., Trisomy 5 and trisomy 7 are nonrandom aberrations in pigmented villonodular synovitis: confirmation of trisomy 7 in uncultured cells. Genes Chromosomes Cancer 1992; 4: 264-266.
6. Mertens F, Orndal C, Mandahl N, et al., Chromosome aberrations in tenosynovial giant cell tumours and nontumorous synovial tissue. Genes Chromosomes Cancer 1993; 6: 212-217. (Pubitemid 23111755)
7. Dahlen A, Broberg K, Domanski HA, et al., Analysis of the distribution and frequency of trisomy 7 in vivo in synovia from patients with osteoarthritis and pigmented villonodular synovitis. Cancer Genet Cytogenet 2001; 131: 19-24. (Pubitemid 33081153)
8. Sciot R, Rosai J, Dal Cin P, et al., Analysis of 35 cases of localised and diffuse tenosynovial giant cell tumour: a report from the Chromosomes and Morphology (CHAMP) study group. Mod Pathol 1999; 12: 576-579. (Pubitemid 29279709)
9. Ohjimi Y, Iwasaki H, Ishiguro M, et al., Short arm of chromosome 1 aberration recurrently found in pigmented villondular synovitis. Cancer Genet Cytogenet 1996; 90: 80-85. (Pubitemid 26316428)
10. Nilsson M, Hoglund M, Panagopoulos I, et al., Molecular cytogenetic mapping of recurrent chromosomal breakpoints in tenosynovial giant cell tumours. Virchows Arch 2002; 441: 475-480. (Pubitemid 35430463)
11. Brandal P, Bjerkehagen B, Helm S,. Molecular cytogenetic characterization of tenosynovial giant cell tumors. Neoplasia 2004; 6: 578-583. (Pubitemid 39411095)
12. West RB, Rubin BP, Miller MA, et al., A landscape effect in tenosynovial giant-cell tumour from activation of CSF1 expression by a translocation in a minority of tumour cells. Proc Natl Acad Sci USA 2006; 103: 690-695. (Pubitemid 43153087)
13. Seitz M, Loetscher P, Fey MF, et al., Constitutive MRNA and protein production of macrophage colony-stimulating factor but not of other cytokines by synovial fibroblasts from rheumatoid arthritis and osteoarthritis patients. Br J Rheumatol 1994; 33: 613-619. (Pubitemid 24222111)
14. Motoyashi K,. Biological activities and clinical applications of M-CSF. Int J Hematol 1998; 67: 109-122.
15. Fujikawa Y, Quinn JMW, Sabokbar A, et al., The human mononuclear osteoclast precursor circulates in the monocyte fraction. Endocrinology 1996; 139: 4058-4060. (Pubitemid 26284685)
16. Quinn JM, Elliott J, Gillespie MT, et al., A combination of osteoclast differentiation factor and macrophage colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 1998; 139: 4424-4427. (Pubitemid 28513734)
17. Wood GS, Beckstead JH, Medeiros LJ, et al., The cells of giant cell tumour of tendon sheath resemble osteoclasts. Am J Surg Pathol 1988; 12: 444-452.
18. Neale S, Kristelly R, Quinn JMW, et al., Giant cells in pigmented villonodular synovitis express an osteoclast phenotype. J Clin Pathol 1997; 50: 605-608. (Pubitemid 27359521)
19. Mahendra G, Cliskey K, Athanasou NA,. Immunophenotypic distinction between pigmented villonodular synovitis and haemosiderotic synovitis. J Clin Pathol 2010; 63: 75-78.
20. Lau YS, Sabokbar A, Gibbons CLMH, et al., Phenotypic and molecular studies on giant cell tumours of bone and soft tissues. Hum Pathol 2005; 36: 945-954. (Pubitemid 41253379)
21. Athanasou NA, Quinn J,. Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. J Clin Pathol 1990; 43: 997-1004.
22. Minkin C,. Bone acid phosphatase-tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982; 34: 285-290. (Pubitemid 12060442)
23. Horton MA, Lewis D, McNulty K, et al., Monoclonal antibodies to osteoclastoma (giant cell bone tumours): definition of osteoclast specific cellular antigens. Cancer Res 1985; 45: 5663-5669. (Pubitemid 16218570)
24. Grimaud E, Soubigou L, Couillaud S, et al., Receptor activator of nuclear factor κB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol 2003; 163: 2021-2031. (Pubitemid 37310032)
25. Itonaga I, Kudo O, Sabokbar A, et al., Cellular mechanisms of osteoclast formation in giant cell granuloma of the jaw. J Oral Pathol Med 2003; 32: 221-231.
26. Reid I,. Bisphosphates. Skel Radiol 2007; 36: 711-714.
27. Namazi H,. Bisphosphonate in novel treatment for pigmented villonodular synovitis. Ann Surg Oncol 2008; 15: 2350-2351.
28. Adamopoulos I, Edwards J, Wordsworth BP, et al., Mechanisms of osteoclast formation and bone resorption in multicentric reticulohistiocytosis. Human Pathol 2006; 37: 1176-1185. (Pubitemid 44286985)
29. Thomas D, Henshaw R, Skubitz K, et al., Denosumab in patients with giant-cell of bone: an open-label, phase 2 sutdy. Lancet Oncol 2010; 11: 275-280.